Alan Y. Baez Vazquez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alan Y. Baez Vazquez has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Alexander O. Mann
Department of Immunology, Harvard Medical School, Boston, MA, USA
3 shared publications - Daisy Ann Hoagland
Department of Immunology, Harvard Medical School, Boston, USA
3 shared publications - Patricia Rodríguez-Morales
Department of Immunology, Harvard Medical School, Boston, MA, USA
3 shared publications - Ruth A. Franklin
Department of Immunology, Harvard Medical School
3 shared publications Alicia Lai
Department of Immunology, Harvard Medical School, Boston, MA, USA
2 shared publications- Jaechul Lim
College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea
2 shared publications
Latest Publications
- Open Access
Type I interferon primes the alveolar epithelium to receive reparative signals from tissue-resident macrophages
Lung repair in response to viral infection requires integrated communication between epithelial and immune compartments, yet the impact of antiviral mediators on epithelial regenerative capacity remains poorly defined. Here, we demonstrate that type I interferon (IFN-I) signaling primes the lung for alveolar renewal following viral challenge. IFN-I contributes to the induction of an interferon-stimulated gene-high (ISG) hi Sca-1 Pos population of alveolar type II (ATII) epithelial cells. Sca-1 Pos ATIIs exhibit enhanced proliferative capacity and increased organoid-forming efficiency compared with their Sca-1 Neg counterparts. Viral challenge concurrently drives phenotypic reprogramming of tissueresident alveolar macrophages (trAMs). Sca-1 Pos ATIIs display heightened responsiveness to oncostatin M (OSM) and, following viral challenge, require trAM-derived OSM for their proliferation. Together, these findings reveal that viral stimuli induce coordinated IFN-I-dependent epithelial and macrophage states that poise the lung for regeneration, positioning IFN-I not only as a central antiviral defense mechanism but as a priming signal that prepares lung tissue for renewal.
Open AccessType I interferon primes the alveolar epithelium to receive reparative signals from tissue-resident macrophages
Lung repair in response to viral infection requires integrated communication between epithelial and immune compartments, yet the impact of antiviral mediators on epithelial regenerative capacity remains poorly defined. Here, we demonstrate that type I interferon (IFN-I) signaling primes the lung for alveolar renewal following viral challenge. IFN-I contributes to the induction of an interferon-stimulated gene-high (ISG) hi Sca-1 Pos population of alveolar type II (ATII) epithelial cells. Sca-1 Pos ATIIs exhibit enhanced proliferative capacity and increased organoid-forming efficiency compared with their Sca-1 Neg counterparts. Viral challenge concurrently drives phenotypic reprogramming of tissueresident alveolar macrophages (trAMs). Sca-1 Pos ATIIs display heightened responsiveness to oncostatin M (OSM) and, following viral challenge, require trAM-derived OSM for their proliferation. Together, these findings reveal that viral stimuli induce coordinated IFN-I-dependent epithelial and macrophage states that poise the lung for regeneration, positioning IFN-I not only as a central antiviral defense mechanism but as a priming signal that prepares lung tissue for renewal.
- Top Cited Papers
- 10 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 389 (6756) , 169-175
Macrophage-derived oncostatin M repairs the lung epithelial barrier during inflammatory damage
Tissue repair programs must function alongside antiviral immunity to restore the lung epithelial barrier following infection. We found that macrophage-derived oncostatin M (OSM) counteracted the pathological effects of type I interferon (IFN-I) during infection and damage in mice. At baseline, OSM-deficient mice exhibited altered alveolar type II (ATII) epithelial cell states. In response to influenza or viral mimic challenge, mice lacking OSM exhibited heightened IFN-I responses and increased mortality. OSM delivery to the lung induced ATII proliferation and was sufficient to protect deficient mice against morbidity. Furthermore, OSM promoted organoid formation despite the growth-inhibitory effects of IFN-I. These findings identify OSM as an indispensable macrophage-derived growth factor that maintains the homeostasis of lung epithelial cells and promotes their proliferation to overcome IFN-I–mediated immunopathology.
- 10 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 389 (6756) , 169-175
Top Cited PapersMacrophage-derived oncostatin M repairs the lung epithelial barrier during inflammatory damage
Tissue repair programs must function alongside antiviral immunity to restore the lung epithelial barrier following infection. We found that macrophage-derived oncostatin M (OSM) counteracted the pathological effects of type I interferon (IFN-I) during infection and damage in mice. At baseline, OSM-deficient mice exhibited altered alveolar type II (ATII) epithelial cell states. In response to influenza or viral mimic challenge, mice lacking OSM exhibited heightened IFN-I responses and increased mortality. OSM delivery to the lung induced ATII proliferation and was sufficient to protect deficient mice against morbidity. Furthermore, OSM promoted organoid formation despite the growth-inhibitory effects of IFN-I. These findings identify OSM as an indispensable macrophage-derived growth factor that maintains the homeostasis of lung epithelial cells and promotes their proliferation to overcome IFN-I–mediated immunopathology.
- Open Access
Macrophages control pathological interferon responses during viral respiratory infection
Antiviral immune mediators, including interferons and their downstream effectors, are critical for host defense yet can become detrimental when uncontrolled. Here, we identify a macrophage-mediated anti-inflammatory mechanism that limits type I interferon (IFN-I) responses. Specifically, we found that cellular stress and pathogen recognition induce Oncostatin M (OSM) production by macrophages. OSM-deficient mice succumbed to challenge with influenza or a viral mimic due to heightened IFN-I activation. Macrophage-derived OSM restricted excessive IFN-I production by lung epithelial cells following viral stimulation. Furthermore, reconstitution of OSM in the respiratory tract was sufficient to protect mice lacking macrophage-derived OSM against morbidity, indicating the importance of local OSM production. This work reveals a host strategy to dampen inflammation in the lung through the negative regulation of IFN-I by macrophages. One-Sentence Summary Type I interferons induced by viral stimuli are negatively regulated by macrophage-derived Oncostatin M.
Open AccessMacrophages control pathological interferon responses during viral respiratory infection
Antiviral immune mediators, including interferons and their downstream effectors, are critical for host defense yet can become detrimental when uncontrolled. Here, we identify a macrophage-mediated anti-inflammatory mechanism that limits type I interferon (IFN-I) responses. Specifically, we found that cellular stress and pathogen recognition induce Oncostatin M (OSM) production by macrophages. OSM-deficient mice succumbed to challenge with influenza or a viral mimic due to heightened IFN-I activation. Macrophage-derived OSM restricted excessive IFN-I production by lung epithelial cells following viral stimulation. Furthermore, reconstitution of OSM in the respiratory tract was sufficient to protect mice lacking macrophage-derived OSM against morbidity, indicating the importance of local OSM production. This work reveals a host strategy to dampen inflammation in the lung through the negative regulation of IFN-I by macrophages. One-Sentence Summary Type I interferons induced by viral stimuli are negatively regulated by macrophage-derived Oncostatin M.
- 6 August 2023
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 179, 113980
Pharmaceutical agent cetylpyridinium chloride inhibits immune mast cell function by interfering with calcium mobilization
- 6 August 2023
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 179, 113980
Pharmaceutical agent cetylpyridinium chloride inhibits immune mast cell function by interfering with calcium mobilization
- 1 September 2014
- Published by JLE in Nephrologie & Therapeutique
- Vol. 10 (5) , 284
Cask soluble une nouvelle molécule impliquée dans la hyalinose segmentaire et focale
- 1 September 2014
- Published by JLE in Nephrologie & Therapeutique
- Vol. 10 (5) , 284
Cask soluble une nouvelle molécule impliquée dans la hyalinose segmentaire et focale